BioSpace News Archive

Lineage Cell Therapeutics, Inc. today reported financial and operating results for the fourth quarter and full year ended December 31, 2022 and will host a conference call today at 4:30 p.m. Eastern Time to discuss these results.

UroGen Pharma Ltd. today announced that it will report fourth quarter and full-year 2022 financial results on Thursday, March 16, 2023, prior to the open of the stock market.

Alpha Tau Medical Ltd. reported full year 2022 financial results and provided a corporate update.

CytoSorbents Corporation today reported financial and operating results for the quarter and year ended December 31, 2022 and provides its 2023 outlook.

SomaLogic, Inc., a leader in proteomics technology, today announced that it will report financial results for the fourth quarter and full year 2022 after market close on Tuesday, March 28, 2023.

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that new data from RE-KINECT ™ , the largest real-world, observational, multicenter study of antipsychotic-treated patients with possible tardive dyskinesia (TD), was published in the Journal of Patient-Reported Outcomes.

Geron Corporation today announced that it will release its fourth quarter and full-year 2022 financial results after the market closes on Thursday, March 16, 2023 via press release, which will be available on the Company’s website at www.geron.com/investors.

Merrimack Pharmaceuticals, Inc. announced its full year 2022 financial results for the period ended December 31, 2022.

Amgen will present at the 2023 Oppenheimer Healthcare Conference at 2:00 p.m. ET on Monday, March 13, 2023.

MediciNova, Inc. announced a modification to its contract with the BARDA, a part of the Administration for Strategic Preparedness and Response in the U.S. Department of Health and Human Services, to repurpose MN-166 as a potential medical countermeasure against chlorine gas-induced lung damage such as acute respiratory distress syndrome and acute lung injury.